The Pharmaceutical Pricing Board’s Swedish and English language e-service for companies has been launched. In our e-service, a company can submit electronic applications for medicinal products, clinical ... Read more
The Swedish and English language application instruction pages have been updated to correspond to the Finnish language pages in terms of structure. As part of the update, the presentation ... Read more
The Pharmaceuticals Pricing Board held horizon scanning hearings for pharmaceutical companies in December 2025. Interest in the events was high, and not all companies could ... Read more
The application instructions for a new medicinal product issued by the Pharmaceuticals Pricing Board have been updated. The changes concern the national price and ... Read more
The application of the EU HTA Regulation began in January 2025. Initially, the regulation applies to new cancer medicines and advanced therapy medicinal products (ATMPs) ... Read more
The application instructions for preparing a health economic evaluation to be attached to the application for reimbursement status and wholesale price for a medicinal product ... Read more
To ensure the functionality of the Office files, use of old file formats (.doc, .xls and .ppt) will be discontinued on April 1, 2024. In ... Read more
Pharmaceuticals Pricing Board (HILA), Finnish Medicines Agency (Fimea), Council for Choices in Health Care in Finland (COHERE Finland), Finnish Coordinating Center for Health Technology Assessment ... Read more
The application instructions for preparing a health economic evaluation to be attached to the application for reimbursement status and wholesale price for a medicinal product ... Read more
There will be no e-service available in October. In October, new applications as well as supplements and additional information on pending applications should be submitted ... Read more
The Pharmaceuticals Pricing Board’s new e-service will be introduced at the turn of October and November 2023. The service will first be launched in Finnish. Read more
In the future, a reference price group will be formed of interchangeable medicinal products if the reference price group includes at least two reimbursable medicinal ... Read more
Starting 1 April 2023, a wider selection of inhaled medicinal products will become eligible for substitution. At the same time, packages that contain a delivery ... Read more
Pharmaceuticals Pricing Board (HILA), Finnish Medicines Agency (Fimea), Social Insurance Institution (KELA) and Finnish Coordinating Center for Health Technology Assessment (FinCCHTA) organize a hearing on ... Read more
The Finnish government agencies have tendered electronic invoice service provider. At this time Posti Messaging/OpusCapita is the Finnish Government’s electronic invoicing service provider and Finnish ... Read more
The email addresses of staff members at the Ministry of Social Affairs and Health will change to the format firstname.lastname@gov.fi on 20 September 2021. Messages ... Read more
This notice contains information on a number of important points about substitutable medicinal products and quarterly price notifications. It is a collaboration of Kela, Fimea ... Read more
The Pharmaceuticals Pricing Board has updated the application instructions for basic ointments and the application instructions for medicinal products subject to marketing authorisation when the ... Read more
In March, Suomi.fi e-authorisations will be taken into use in the e-Service of the Pharmaceuticals Pricing Board. The introduction is planned for week 12. Due ... Read more